semaglutide weight loss program glen mills pa StudioMD | GLP-1 medications are changing lives, but rapid affects more than just the number on the scale, and most patients aren't warned April Special: GLP-1 Weight Loss

BMC Obes

Kaufman worried that so many patients will drop out that the drug will be considered a failure

[DOI] [PubMed] [Google Scholar] Timmerman LA, Clipstone NA, Ho SN, Northrop JP, Crabtree GR

Semaglutide, a GLP-1 receptor agonist, has three brand names: Ozempic, Wegovy, and Rybelsus, each approved by the FDA for different indications

2 Less common but significantly more severe side effects have been documented, including gastroparesis, pancreatitis, kidney complications, the development of arthritis, vision loss and possibly even thyroid cancer

Coverage already exists for these, and label expansion increases the return in the ROI equation for both drug manufacturers and health plans